Pfizer, GSK and Teva lead 2022’s round of January drug price hikes: GoodRxnews2022-01-04T16:30:30+00:00January 4th, 2022|Fierce Pharma|
Third former GlaxoSmithKline scientist pleads guilty to stealing company secretsnews2022-01-04T14:57:34+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: Pfizer doubles Paxlovid supply to US; A 4th Comirnaty vaccine dose?news2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: Pfizer targets April for Comirnaty kids data; Bharat Biotech, Gavi mull Covaxin supplynews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: J&J says shot protection lasts 6 monthsnews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: Pfizer shot less effective for kids ages 5 to 11; Novavax sees $4B-$5B in sales this yearnews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: J&J shot less effective than Pfizer’s against hospitalization, study saysnews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: WHO recommends Merck’s pill; Regeneron faces patent lawsuit for COVID trialsnews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: FDA rejects Ocugen-Bharat COVID vax for 2-18 year-olds; Japan, U.K. pledge $500M to CEPInews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
COVID-19 tracker: Even mild COVID cases can have significant impacts on the brain, study says; World COVID death toll tops 6Mnews2022-01-04T14:42:10+00:00January 4th, 2022|Fierce Pharma|
